We manufacture and distribute fine chemicals and laboratory
products - with quality and delivery you can count on every time.

Corner
acumedia<sup>®</sup> Pseudomonas Cepacia Agar

acumedia® Pseudomonas Cepacia Agar

• Intended Use: Pseudomonas Cepacia Agar is used for the selective isolation and detection of Pseudomonas cepacia (Burkholderia
cepacia) from clinical and non-clinical specimens.
• Product Summary and Explanation: Pseudomonas cepacia was first described as a phytopathogen, and isolated from rotting
onions and various soil and animal sources. In recent years Pseudomonas cepacia has become an opportunist, causing
nosocomial infections including endocarditis, pneumonia, wound, and urinary tract infections. This organism has been isolated
from disinfectants, nebulizers, incubators, and intraveous fluids in hospitals worldwide. P. cepacia causes chronic lung infections
in cystic fibrosis patients, and can lead to life-threatening systemic complications. P. cepacia is highly resistant to
aminoglycosides and other antibiotics, making it difficult to treat.

In 1985 Gilligan et al. developed Pseudomonas Cepacia Agar. This medium has shown good recovery of P. cepacia, even among mixed populations. Some P. cepacia strains produce a nonfluorescent phenazine pigment, while others nonpigmented. A sweet odor similar to that associated with P. aeruginosa is produced by some strains.

Image(s) are representative of the product group and not necessarily the individual product.
Catalog Item Availability Mfr. Part # List Price Unit
741-60557 Pseudomonas Cepacia Agar, 500 g - 500 g

7458-500g $116.10 EA
741-60557-5KG Pseudomonas Cepacia Agar, 5 kg - 5 kg

7458T $1053.30 EA
741-60557 Pseudomonas Cepacia Agar, 10 kg - 10 kg

7458-10kg $2127.65 EA

Description Back to Top

• Intended Use: Pseudomonas Cepacia Agar is used for the selective isolation and detection of Pseudomonas cepacia (Burkholderia
cepacia) from clinical and non-clinical specimens.
• Product Summary and Explanation: Pseudomonas cepacia was first described as a phytopathogen, and isolated from rotting
onions and various soil and animal sources. In recent years Pseudomonas cepacia has become an opportunist, causing
nosocomial infections including endocarditis, pneumonia, wound, and urinary tract infections. This organism has been isolated
from disinfectants, nebulizers, incubators, and intraveous fluids in hospitals worldwide. P. cepacia causes chronic lung infections
in cystic fibrosis patients, and can lead to life-threatening systemic complications. P. cepacia is highly resistant to
aminoglycosides and other antibiotics, making it difficult to treat.

In 1985 Gilligan et al. developed Pseudomonas Cepacia Agar. This medium has shown good recovery of P. cepacia, even among mixed populations. Some P. cepacia strains produce a nonfluorescent phenazine pigment, while others nonpigmented. A sweet odor similar to that associated with P. aeruginosa is produced by some strains.

Image(s) are representative of the product group and not necessarily the individual product.

Certifications Back to Top

Shipping Back to Top

Shipping Costs
Click here for Shipping Costs
313572 has a rating of 4.9 stars based on 10 reviews.